This study aimed to evaluate a microemulsion system (ME) containing phenobarbital in epilepsy model induced by pilocarpine in rats and to oxidative stress and histologic lesions in hippocampus. The microemulsion was applied to the shaved back of Wistar rats. The animals were divided into the following groups: control group (P400); ME50 40 mg/kg, topically-t.p.; ME100, 40 mg/kg, t.p.; EM50, 40 mg/kg, t.p.; phenobarbital solution 40 mg/kg (PS), oral. After 60 min, behavioral changes were evaluated for 1 h in the model of epileptical crisis induced by pilocarpine. Phenobarbital in microemulsion was able to increase the latency for status epilepticus (SE) (p b 0.05), decrease the number of epileptical crisis (ME50: p b 0.001; ME100: p b 0.01) and decrease mortality rate by 80% compared to P400. In EM50 and PS groups, deaths were decreased by 53.3% and 100% respectively. The ME50 and ME100 groups were able to reduce oxidative stress in experimental animals when compared to the P400. The microemulsion was still capable of reducing neuronal damage in the hippocampal areas. The results of this study come in an innovative way, demonstrating the ability of transdermal ME50 and ME100 to reduce pilocarpine-induced epileptical crisis, oxidative stress, besides neuronal damages.
Introduction
Epilepsy is a brain disorder caused by the brain enduring predisposition to generate epileptic crisis and by the neurobiological, cognitive, psychosocial and social consequences of the condition characterized by the occurrence of at least one crisis (Guilhoto et al., 2006) . Approximately 50 million people worldwide are living with epilepsy. According to some literature data, the prevalence of this condition in Brazil can vary from 5.4 to 36.8/per 1000 inhabitants (Gomes et al., 2002; Kanashiro, 2006) . Epilepsy is considered the second most frequent cause of neurological disorder in young adults (Betting et al., 2003) , with an overall incidence of approximately 1% in children (Yacubian, 2002) .
Several animal models of epilepsy are used to study the pathophysiology of the convulsive process and the antiepileptic activity of drugs in pre-clinical evaluation (Freitas et al., 2006) . The use of pilocarpine in rodents is an optimal animal model of induced epileptical crisis, with great similarities in functional impact and morphological changes to the temporal lobe epilepsy in humans (Cavalheiro et al., 1987 ). An increase in lipid peroxidation and in nitrite levels as well as decreased levels of reduced glutathione (GSH) and excessive production of free radicals have been observed during crisis induced by pilocarpine (Freitas et al., 2005) . This model has been successfully used to evaluate the antiepileptic action of new drugs (Scorza et al., 2009) , as well as new drug delivery system (Moreno et al., 2011) .
In the last decade a major breakthrough in the treatment of epilepsy including the discovery of new drugs, new formulations of old drugs, vagal stimulation, ketogenic diet, as well as surgical treatment has been observed (Betting et al., 2003) . As a general strategy for the treatment of majority of cases indicated for crisis control is the use of drugs in monotherapy (Dalmora et al., 2010) .
Among those drugs, phenobarbital is a barbiturate used to treat different forms of pediatric epilepsy and status epilepticus, being considered first line for the control of neonatal seizures (Djabri et al., 2012) . It presents advantages like low cost, broad spectrum of action and ease of use (Dalmora et al., 2010) . Phenobarbital is a centenary drug and it is still considered the most cost-effective pharmacological treatment of epilepsy, mainly for developing countries (Brodie and Kwan, 2012) .
It is one of the drugs of choice in the treatment of status epilepticus and febrile seizures (Pastore et al., 2007) . Phenytoin and/or benzodiazepines are usually recommended as initial treatment of epileptic seizures in general, but when these drugs fail to control seizures, phenobarbital is often used (Walton and Treiman, 1989) . It has good oral bioavailability, but may have fluctuations in plasma levels in pediatric patients. In addition, it may reduce bioavailability and makes a difference of up to 60% when compared to a parenteral route of administration (Touw et al., 2000; Yukawa et al., 2011) . Furthermore, the narrow therapeutic window of this antiepileptic is one of the aggravating factors for the treatment of seizures, since a usual dose can lead its plasma concentrations to toxic levels.
In the literature, there are several papers describing the study of alternative formulations available in the market for the drug phenobarbital. Among these formulations, there can be cited: suppositories (Moolenaar et al., 1979) ; oral suspension (Yska et al., 2000; Morantes et al., 2010) ; oral solution (Jelveghari and Nokhodchi, 2008) ; hydrogel and emulsion for transdermal use (Odria et al., 2005) . There are also studies about new drug delivery system, such as skin penetration of phenobarbital using iontophoresis (Djabri et al., 2012) . Several studies have been moving towards the implementation of innovative formulations, such as microemulsions as a carrier for various drugs (El-Setouhy and El-Ashmony, 2010; Damasceno et al., 2011; Meng and Hu, 2011) .
The microemulsions are thermodynamically stable and nanosized droplets of two immiscible liquids (usually oil and water) stabilized by a surfactant film composite, located in the oil/water interface systems (Oliveira et al., 2004) . The microemulsion systems can promote skin penetration of various drugs. In general, in transdermal administration, dermal penetration of drugs is limited as the skin is an important biological barrier that leaves only a few substances to penetrate under certain conditions. The use of the transdermal route offers advantages in different circumstances compared to other routes of administration. It avoids the adversities of oral route, it is painless, non-invasive and easy to apply, and may increase, thus, patient adherence to the therapy (Silva et al., 2009 (Silva et al., , 2010 .
In view of the numerous advantages of transdermal administration of phenobarbital incorporated into microemulsion, the aim of this study was to evaluate a microemulsion system containing this antiepileptic in epilepsy model induced by pilocarpine in rats and to measure oxidative stress by biochemical markers and histologic lesions in brain areas.
Materials and methods

Animals
Female Wistar rats (n = 8-15/group), weighing 180-240 g, were purchased from the Central Animal Facility of the Center for Agricultural Sciences of UFPI. These were housed in a room maintained at 25 ± 1°C with an alternating of 12 h of light-dark cycle. The hairs of the dorsum were removed in an area of 4 cm 2 through electric shaver. All experiments proposed were previously submitted for consideration by the Ethics Committee on Animal Experimentation of UFPI (research n. 0102/12 approved on 10 Dec 2012).
Preparation of samples for treatment
Pilocarpine hydrochloride (Vegeflora, Brazil) was dissolved in purified water (distilled water) to obtain a final concentration of 4 mg/ml. Phenobarbital (PharmaNostra, Brazil, Lot. N. 10083132B) was dissolved in purified water with 1% polyssorbate 80 v/v (Vetec, Brazil).
The microemulsion was prepared by mixing cold capryl caproyl macrogol-8 glyceride -labrasol® (Gattefosse, France), ethanol (Dynamic, Brazil), isopropyl myristate (Synth, Brazil) and purified water (Millipore, Germany) under magnetic stirring (100 rpm). Constituents were mixed in the following order, followed by stirring for 20 min between steps: 1. labrasol® and ethanol; 2. isopropyl myristate; 3. purified water; 4. Phenobarbital. A drug was incorporated without heating in concentrations of 50 mg/g (ME50) and 100 mg/g (ME100). In the preparation of the emulsion with phenobarbital to 50 mg/g (EM50) was used an self-emulsionant nonionic wax (PharmaNostra, Brazil), methylparaben (Vetec, Brazil), propylparaben (Vetec, Brazil), propylene glycol (Vetec, Brazil) and purified water (Millipore, Germany).
Behavioral study in pilocarpine-induced epilepsy model
An amount corresponding to 40 mg/kg of phenobarbital microemulsion was applied to the shaved backs of Wistar rats. This dose was tested and standardized according to data from previous studies, being less than that which prevented motor seizures induced by homocysteine thiolactone in an American study, with an ED 50 of 47 mg/kg (Walton and Treiman, 1989) .
The animals were divided into the following groups: control group (P400); ME50 40 mg/kg, topically -t.p.; ME100 40 mg/kg, t.p.; EM50, 40 mg/kg, t.p.; phenobarbital solution 40 mg/kg (PS), oral, used as a reference group. After 60 min, the groups were treated with pilocarpine 400 mg/kg, intraperitoneally -i.p. (P400) and behavioral changes were evaluated in 1 h and the number of deaths was recorded within 24 h after administration (Turski et al., 1989; Freitas et al., 2006) .
The groups were placed in cages 30 cm × 30 cm to observe the following behavioral parameters: peripheral cholinergic signs (PCS), tremors, stereotyped movements (SM), seizures, status epilepticus (SE) and number of survivors, latency installation of first seizure and the latency of development of SE. Drug doses used were standardized prior to conducting this experimental protocol.
Evaluation of oxidative stress in rat hippocampus
At the end of the previous experiment, the animals were killed by decapitation and the brains were dissected on ice with hippocampal removal for the determination of the levels of lipid peroxidation, nitrite and reduced GSH. The levels of these markers in animals which received only vehicle (not pilocarpine) were also evaluated.
Determination of lipid peroxidation and the content of nitrite
Lipid peroxidation was assessed by determining the levels of acid reactive substances to thiobarbituric acid (TBARS) as previously described by Draper and Hadley (1990) . Homogenates were prepared by 10% (w/v) in sodium phosphate buffer 50 mM (pH 7.4) of the brain area of the investigated animals (n = 8) of the following groups: vehicle, (P400), ME50, ME100, EM50 and PS. The samples were incubated with 10% trichloroacetic acid and 0.67% thiobarbituric acid for 60 min in a water bath at 37°°C. After centrifugation, the absorbance of the samples was determined at 535 nm. The results were expressed in mmol malonaldehyde (MDA).g tissue −1 (Freitas et al., 2005) .
The nitrite content in all groups (n = 10) was determined based on the Griess reaction (Green et al., 1981) . Homogenates of the hippocampus were incubated with 10% Griess reagent at room temperature for 10 min. The absorbances were determined shortly thereafter at 550 nm. The concentration of nitrite was determined using a standard curve constructed with nitrite NaNO 2 . The results were expressed in millimolar -mM (Freitas et al., 2005) .
Determination of reduced GSH
The GSH content was determined with some modification of the technique described by Sedlak and Lindsay (1968) . Homogenates at 10% of all groups (n = 8) were prepared in EDTA 0.02 M. The extent of the reaction product formed from 5.5′thiobis (2-nitrobenzoic acid) (DNTB) is done by reading the absorbance at 412 nm. The concentration of GSH was expressed in nanogram of GSH.g tissue −1 (Freitas et al., 2005) .
Histopathological analysis
After undergoing seizures induced by pilocarpine, animals were sacrificed for removal of the brain, being preserved in 10% fomaldeid for making histological sections. Tissues were embedded in paraffin and made cuts of 5 μm with mount in microscope lamina. Lesions in the brain tissue in CA1 (Cornu Ammonis 1) and dentate gyrus regions of the hippocampus were evaluated by light microscopy and images were recorded at 100× magnification.
Results
After intraperitoneal administration of pilocarpine 400 mg/kg, the animals showed similar changes to increased cholinergic behavioral stimulation such as piloerection, chromodacriorrea, tremors, diarrhea, diuresis, salivation and SM of scratching, rearing (lift), chewing, among others, which persisted for 10 to 15 min. These behavioral changes progressed to motor seizures (Turski et al., 1989) , which were observed for 30 to 50 min and then progressed to SE.
After topical application of phenobarbital incorporated into microemulsion, it was observed that there were changes in the parameters analyzed for seizures induced by pilocarpine in the P400 (Table 1) . The embedded phenobarbital at 50 mg/g in microemulsion (ME50), as well as at 100 mg/g (ME100), were able to increase the latency for the onset of first seizure in relation to the P400 group (p b 0.05). There was no change in latency for SE and death of the animals. When it was incorporated in emulsion (EM50), phenobarbital did not increase latency in any of the parameters analyzed. In oral administration, PS group completely inhibited the installation of seizures with onset time 0 min for all parameters.
After transdermal administration at a dose of 40 mg/kg, the microemulsion system containing phenobarbital was able to prevent the development of seizures in 86.7% and 73.4% of the animals in the groups receiving microemulsion, ME50 and ME100, respectively. There was 80% of survivors in both groups, with a difference of 60% inhibition of deaths in relation to P400 (Table 1) . When using EM50, phenobarbital decreased by 60% the development of epileptical crises, with a difference of 26.7% and 13.4% for the groups ME50 and ME100, respectively. EM50 had a surviving rate of 53.3% (26.7% lower compared to groups receiving microemulsion). In the group used as a reference for testings, PS, any deaths among animals was not verified.
Animals that received phenobarbital showed reductions of SM compared to P400 group, by 66.7%, 66.7%, 80% and 66.7% for ME50, ME100, EM50 and PS groups, respectively (Table 2 ). However, this result was not statistically significant for all groups receiving phenobarbital compared to the P400 group for the Fisher test. No reduction of PCS and tremors was observed for the P400 group.
In the evaluation of oxidative stress in the hippocampus of rats submitted to the pilocarpine epilepsy model, we determined the levels of TBARS, nitrite and GSH using in vitro methods.
ME50, ME100 and PS groups were able to reduce by 45%, 27.2% and 43.3% the levels of TBARS per gram of tissue compared to P400, respectively, with statistical significance of p b 0.001 and p b 0.05 (Fig. 1) . ME50 group reduced TBARS more intensively than EM50, observing a difference between these groups (p b 0.01) and PS (p b 0.01). The ME50, M100 and PS groups present levels of this marker in a similar way to the vehicle (p N 0.05). The EM50 group decreased TBARS by only 10.1%, with p N 0.05 in relation to P400 and p b 0.001 in relation to normal animals (vehicle).
Nitrite levels in the groups treated with microemulsion differ when compared to the P400 group, with a reduction by 29.8% and 31.9%, respectively, for ME50 and ME100, with p b 0.05 (Fig. 2) . The same was evident in the PS group, with a reduction of 33.5%. In EM50, the levels of nitrite reduced by 16.6%, but this result was not significant with p N 0.05. ME50, ME100 and EM50 were similar to PS, with p N 0.05. The vehicle group showed lower levels of nitrite in relation to other groups.
GSH levels were significantly increased in all ME50, ME100, EM50 and PS groups, by 51.1% (p b 0.01), 51.7% (p b 0.01), 38.4% (p b0.05) and 54.5% (p b 0.01), respectively, compared to the P400 group (Fig. 3 ). The study groups had similar levels of GSH maintenance of stocks regarding the group P400, but smaller relative to the vehicle (p b 0.001). There was a more pronounced consumption of GSH in EM50 group, which showed a difference of 20.5% and 21.5% in the levels of this antioxidant molecule in relation to groups ME50 and M100, respectively. However, this result was statistically insignificant (p N 0.05).
In Fig. 4 , the histopathological analysis of the hippocampus of animals subjected to seizures induced by pilocarpine can be observed. Clearly the ME50, ME100 and PS groups similarly reduced neuronal lesions in animals of group P400, with preservation of the cells in their histofunctional characteristics (central nucleus, evident nucleolus and cohesive cells). The EM50 group showed impairment of hippocampal cells, with cell death, but less intense than P400, which presented several picnotic cells, vacuolation and degeneration. epilepticus; P400 = pilocarpine 400 mg/kg, ip, n = 15; ME50 = Microemulsion of phenobarbital of 50 mg/g, 40 mg/kg, t.p., n = 15; ME100 = Microemulsion of phenobarbital of 100 mg/g, 40 mg/kg, t.p., n = 15; EM100 = emulsion of phenobarbital of 50 mg/g, 40 mg/kg, t.p., n = 15; PS = Phenobarbital 40 mg/kg, orally, n = 15. a p b 0.05 regarding the group P400 (ANOVA followed by t-Student-Newman-Keuls was tested as post hoc test). *p b0.05, **p b0.01 and ***p b0.001 regarding group P400. Test exact of Fisher. The results were expressed as percentage (%) and the average ± standard error of the average. PCS = peripheral cholinergic signs; SM = stereotyped movements; P400 = pilocarpine 400 mg/kg, i.p., n = 15; ME50 = microemulsion phenobarbital 50 mg/g, 40 mg/kg, t.p., n = 15; ME100 = Microemulsion phenobarbital 100 mg/g, 40 mg/kg, t.p., n = 15; EM50 = emulsion phenobarbital 50 mg/g, 40 mg/kg, t.p., n = 15; PS = Phenobarbital 40 mg/kg, p.o., n = 15. p N 0.05 (Fisher's exact test) . The results were expressed as percentage (%) and mean ± standard error of the average. PCS: peripheral cholinergic signs; SM: stereotyped movements.
Discussion
When systemically administered to rats at a dose of 400 mg/kg, the range of pilocarpine induced persistent behavioral changes is similar to that described in the literature (Freitas et al., 2006) , These were followed by motor limbic seizures, which began after 20-30 min and repeated every 2-5 min, leading then to the SE (Cavalheiro et al., 1987) .
Antiepileptic drugs are able to increase the latency for the installation of the first seizures (Costa et al., 2012) . In this study, ME50, ME100 and PS groups increased the time for the installation of the first seizure when compared with the P400 (Table 1 ). The P400 group showed a similar number of deaths to the work of Clifford et al. (1985) , with 20% of survivals within 24 h after administration of pilocarpine. There was a significant reduction of the number of deaths in ME50 and ME100, with an inhibition for EM50 26.7% shorter than these groups.
Drugs capable of causing inhibition mediated by GABA, such as barbiturates, act through inhibition of voltage-dependent sodium channels in certain neuronal synapses, and reduce or even cease the seizures induced by cholinergic agonists such as pilocarpine (Freitas et al., 2006) . Activation of the GABAergic system does not interfere with peripheral effects mediated by pilocarpine, similar to other drugs that have GABAergic mediation such as diazepam and clonazepam (Freitas et al., 2006; Freitas, 2011) . Phenobarbital was not able to significantly alter the behavioral parameters of Table 2 .
Oxidative stress is defined as the increased production of free radicals in tissues and it can dramatically alter neuronal function during seizures (Dymond and Crandall, 1976) . ME50 and ME100 reduced oxidative stress and neuronal injury in experimental animals when compared to P400, as evidenced by decreased levels of TBARS, nitrite, maintenance of GSH levels and lesions in rat hippocampus (Figs. 1-4) .
Lipid peroxidation can be induced by many chemical agents and it is present in neuronal injuries, such as epilepsy (Flohe and Otting, 1984) . Phenobarbital may be able to reduce neuronal discharges in brain areas such as the hippocampus, as indirectly evidenced by the reduction of the levels of oxidative stress markers, like the production of derivatives of nitric oxide (NO). High levels of TBARS are present under conditions of oxidative stress and they are assessed by determining MDA (Draper and Hadley, 1990) . Under normal conditions, there is a balance between the production of NO and its metabolites (nitrite and nitrate) and their elimination by the antioxidant defense system. In epileptic seizures induced by pilocarpine there is increased formation of nitrite with increased oxidative stress and neuronal damage (Kudin et al., 2004) .
GSH is responsible for the elimination of reactive oxygen species derived (ROS) (Halliwell, 1993) . In cases of oxidative stress ROS levels that exceed the capacity of GSH to scavenge free radicals, there is an increase in the consumption of the antioxidant molecule and a consequent reduction on their levels (Freitas et al., 2005) , as can be noted in the P400 group (Fig. 3) . The administration of phenobarbital in all formulations administered was able to maintain high stocks of GSH in the P400, with lower maintenance thereof in EM50 (around 20% less). The animals were divided into groups: vehicle (negative control, normal animals); P400 (pilocarpine 400 mg/kg, ip); ME50 (Microemulsion phenobarbital 50 mg/g, 40 mg/kg, tp) + P400; ME100 (microemulsion phenobarbital 100 mg/g, 40 mg/kg, tp) + P400; EM50 (emulsion of phenobarbital 50 mg/g, 40 mg/kg, t.p.) + P400; PS (phenobarbital 40 mg/kg, v.o.) + P400. One-way ANOVA, followed by t-Student-Newman-Keuls test as post hoc test. The results were expressed as nmol of MDA/g of tissue. Fig. 2 . Biochemical changes in the levels of nitrite in rat hippocampus after seizures induced by pilocarpine 400 mg/kg i.p. (n = 10). Animals were divided into groups: vehicle (negative control, normal animals); P400 (pilocarpine 400 mg/kg, ip); ME50 (Microemulsion phenobarbital 50 mg/g, 40 mg/kg, t.p.) + P400; ME100 (microemulsion phenobarbital 100 mg/g, 40 mg/kg, tp) + P400; EM50 (Emulsion phenobarbital 50 mg/g, 40 mg/kg, tp) + P400; PS (phenobarbital 40 mg/kg v.o.) + P400. One-way ANOVA, followed by t-Student-Newman-Keuls test as post hoc test. The results were expressed as mM. Fig. 3 . Biochemical changes in GSH levels in rat hippocampus after seizures induced by pilocarpine 400 mg/kg i.p. (n = 8) animals were divided into groups: vehicle (negative control, normal animals); P400 (pilocarpine 400 mg/kg, ip); ME50 (Microemulsion phenobarbital 50 mg/g, 40 mg/kg, t.p.) + P400; ME100 (microemulsion phenobarbital 100 mg/g, 40 mg/kg, tp) + P400; EM50 (Emulsion phenobarbital 50 mg/g, 40 mg/kg, tp) + P400; PS (phenobarbital 40 mg/kg, v.o.) + P400. One-way ANOVA followed by t-StudentNewman-Keuls test as post hoc test. The results were expressed as mg/g tissue.
In the histological analysis of the rat hippocampus, the P400 group showed typical histological neuronal damage induced by pilocarpine (Nascimento, 2004) , but ME50 and ME100 groups presented a reduction of such lesions in the hippocampus (Fig. 4) . This result corroborates the findings on reduction in number of crisis, deaths and regulation of markers of oxidative stress in the test animals, similar to the results of the work by Liu et al. (2012) for baicaline. ME50, ME100 and PS results are higher than the EM50 ones in reducing lesions in rat hippocampus, which demonstrates a possibly neuroprotection derived from the reduction of discharges of epileptic neuronal (Pitkanen, 2002) , crises as well as from the reduction of oxidative stress in brain area evaluated (Tomé et al., 2010) .
The transdermal way has potential application for chronic drug therapy, as the treatment of epilepsy. Some authors have suggested that the transdermal route to phenobarbital (Djabri et al., 2012) , is similar to other psychoactive drugs, such as clonazepam, clonazepam and bupropion (Puglia et al., 2001; Tsai et al., 2011) . Bonina et al. (1993) demonstrated the ability of this antiepileptic drug to permeate through the skin layers of humans and animals, making it a promising drug for transdermal delivery systems, such as microemulsions.
Microemulsions offer advantages over traditional formulations, which typically have a low ability to solubilize lipophilic drugs, such as gels. Microemulsions can promote hydration of the corneum stratum and thus facilitate the permeation of drugs transdermally (Sabale and Vora, 2012) , and they may have better outcomes than a cream (Aggarwal et al., 2013) . In addition, microemulsions act as permeation enhancers through the layers of the skin due to the small size of the droplets, as well as its high content of surfactant that contributes to the disruption of the lipids of the skin (Silva et al., 2010) . Such surfactants allow interaction with the stratum corneal through disruption of the lipid bilayer and the permeability of the drug is facilitated (Damasceno et al., 2011) . Moreover, the nanosized droplets presented in this microemulsion can play a key role in cutaneous penetration of phenobarbital (data not shown).
The Labrasol® surfactant is a derivative of polyethylene glycol with low dermal irritability and it has been used in various microemulsion compositions with good transdermal permeation (Zhao et al., 2006; Butani et al., 2014; Üstündağ Okur et al., 2014) . Furthermore, the oily phase, then the isopropyl myristate, has characteristics of a transdermal permeation enhancer (Nokhodchi, 2003) , which may have contributed to the results from ME50 and ME100. Moreover, EM50 showed lower results compared to the microemulsion. Conventional emulsions have a relatively large particle size and often exhibit characteristics of release and transdermal permeation of different drug microemulsion systems, as shown in Teichmann (2007) .
The proportional decrease in the quantity of microemulsion administered in ME100 group (given that the dose was the same for all groups) and the consequent reduction of surface area of the skin that received the microemulsion may have contributed to the slight differences observed in the percentage of seizure and levels of TBARS compared to ME50 group (Table 1 and Fig. 1) .
The results of this study come from an innovative way to demonstrate the ability of transdermal microemulsion containing phenobarbital to reduce epileptic seizures induced by pilocarpine, oxidative stress and the consequent neuronal damage in experimental animals. Thus, the use of such a microemulsion may have potential application as a transdermal release system in antiepileptic therapy, and it may minimize the inter-individual variation in pharmacokinetics of phenobarbital in pediatrics when administered orally (Sweetman, 2007) , as well as facilitate its adherence in chronic use. However, subsequent pharmacokinetic studies are needed to better assess the differences observed in relation to the oral route in terms of bioavailability.
Conclusion
From the results of this study, it was observed that phenobarbital incorporated into microemulsion was able to increase the latency for the installation of seizures, reduce its percentage and number of deaths, as well as reduce oxidative stress and neuronal damage in the hippocampus of mice. These findings reinforce the hypothesis of the use of microemulsion containing phenobarbital as nanocarrier with potential application for transdermal use in the treatment of epilepsy.
